(Q35140898)

6 August 2017

1 reference

title

The expanding spectrum of renal diseases associated with antiphospholipid syndrome (English)

1 reference

6 August 2017

11

Jean-Charles Piette

1 reference

6 August 2017

12

Philippe Lesavre

1 reference

6 August 2017

1

Fadi Fakhouri

1 reference

6 August 2017

2

Laure-Hélène Noël

1 reference

6 August 2017

10

Jean-Pierre Grünfeld

1 reference

6 August 2017

8

Dominique Chauveau

1 reference

6 August 2017

Julien Zuber

3

1 reference

6 August 2017

Hélène Beaufils

4

1 reference

6 August 2017

Frank Martinez

5

1 reference

6 August 2017

Pierre Lebon

6

1 reference

6 August 2017

Thomas Papo

7

1 reference

6 August 2017

Olivier Bletry

9

1 reference

6 August 2017

publication date

1 June 2003

1 reference

American Journal of Kidney Diseases

6 August 2017

published in

1 reference

6 August 2017

volume

41

1 reference

6 August 2017

issue

6

1 reference

6 August 2017

page(s)

1205-1211

1 reference

International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900352-4

7 January 2021

Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900352-4

7 January 2021

Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900352-4

7 January 2021

Acute renal failure due to bilateral renal artery thrombosis associated with primary antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900352-4

7 January 2021

Renal manifestations of the antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900352-4

7 January 2021

Renal infarction and thrombosis of the infrarenal aorta in a 35-year-old man with primary antiphospholipid syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900352-4

7 January 2021

Renal disorders in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900352-4

7 January 2021

Massive proteinuria as a main manifestation of primary antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900352-4

7 January 2021

Idiopathic membranous glomerulonephritis associated with primary antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900352-4

7 January 2021

Prevalence of antiphospholipid antibodies in nephropathies not due to systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900352-4

7 January 2021

Recurrent Glomerulonephritis After Renal Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900352-4

7 January 2021

Complement C3 activation is required for antiphospholipid antibody-induced fetal loss

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900352-4

7 January 2021

Association of cerebral vasculitis with a lupus anticoagulant. A case with brain pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900352-4

7 January 2021

Glomerular lesions in lymphomas and leukemias

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900352-4

7 January 2021

Thymoma associated with myasthenia gravis and minimal lesion nephrotic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900352-4

7 January 2021

Antiphospholipid antibodies in patients with Wegener's granulomatosis and polyarteritis nodosa

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900352-4

7 January 2021

Anticardiolipin antibodies in giant cell arteritis and polymyalgia rheumatica: a study of 40 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900352-4

7 January 2021

Vasculitis in the antiphospholipid syndrome. A cause of ischemia responding to corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900352-4

7 January 2021

Primary antiphospholipid syndrome and self-limited renal vasculitis during pregnancy: case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900352-4

7 January 2021

Microscopic polyangiitis associated with antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900352-4

7 January 2021

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900352-4

7 January 2021

Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900352-4

7 January 2021

Lupus band test yields negative results in primary antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900352-4

7 January 2021

The management of thrombosis in the antiphospholipid-antibody syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900352-4

7 January 2021

10.1016/S0272-6386(03)00352-4

Identifiers

DOI

1 reference

6 August 2017

1 reference